RU1836371C - Способ получени производных 5,5а,6,7,8,9,9а,10-октагидропиридо (2,3- @ )-хинолина или их фармацевтически приемлемых солей - Google Patents

Способ получени производных 5,5а,6,7,8,9,9а,10-октагидропиридо (2,3- @ )-хинолина или их фармацевтически приемлемых солей

Info

Publication number
RU1836371C
RU1836371C SU904830582A SU4830582A RU1836371C RU 1836371 C RU1836371 C RU 1836371C SU 904830582 A SU904830582 A SU 904830582A SU 4830582 A SU4830582 A SU 4830582A RU 1836371 C RU1836371 C RU 1836371C
Authority
RU
Russia
Prior art keywords
quinoline
pharmaceutically acceptable
acceptable salts
reagent
octahydropyrido
Prior art date
Application number
SU904830582A
Other languages
English (en)
Inventor
Мехнерт Шаус Джон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Application granted granted Critical
Publication of RU1836371C publication Critical patent/RU1836371C/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Использование: в качестве агонистов доламина. Сущность изобретени : продукт - производные 5,5а,6,7,8,9,9э,10-октагидро- пиридо(2,3-а)хинолина общей ф-лы 1 или 2: VN-R где X - галоид, водород или группа -NRiR2, где RI и RZ - каждый в отдельности водород, Ci-Ce-алкил, Ci-Сб-алкилфенил, или RI и R2 - вместе вз тые с атомом азота, к которому они присоединены, образуют ПИррОЛИДИН, R - С1-С4-ЗЛКИЛ, ИЛИ ИХ фармацевтически приемлемые соли. Реагент 1: соединение общей ф-лы 3 или 4 где R - Ci-d-алкил. Реагент 2- дегидратирующий галогенирующий агент, такой, как ок- сихлорид фосфора. Реагент 3: амин общей ф-лы: NHRiR2, где RI и R2 - указано выше. Услови  реакции: в среде органического растворител . 2 табл. 00 со о 00 VI

Description

Таблица 1
Ингибирование сывороточного лролактина
Все соединени  были введены в виде рацемической смеси.
11183637112
Таблица 2 Данные по ингибированию пролэктина соединени  из уровн  техники
SU904830582A 1989-07-24 1990-07-23 Способ получени производных 5,5а,6,7,8,9,9а,10-октагидропиридо (2,3- @ )-хинолина или их фармацевтически приемлемых солей RU1836371C (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/383,673 US4939259A (en) 1989-07-24 1989-07-24 2-oxo-pyrido[2,3-g]quinoline derivatives

Publications (1)

Publication Number Publication Date
RU1836371C true RU1836371C (ru) 1993-08-23

Family

ID=23514174

Family Applications (1)

Application Number Title Priority Date Filing Date
SU904830582A RU1836371C (ru) 1989-07-24 1990-07-23 Способ получени производных 5,5а,6,7,8,9,9а,10-октагидропиридо (2,3- @ )-хинолина или их фармацевтически приемлемых солей

Country Status (14)

Country Link
US (1) US4939259A (ru)
EP (1) EP0410641A3 (ru)
JP (1) JPH0395182A (ru)
KR (1) KR910002853A (ru)
CN (1) CN1049162A (ru)
AU (1) AU631228B2 (ru)
CA (1) CA2021314A1 (ru)
HU (1) HU207079B (ru)
IE (1) IE902674A1 (ru)
MX (1) MX21657A (ru)
NZ (1) NZ234550A (ru)
PT (1) PT94749A (ru)
RU (1) RU1836371C (ru)
ZA (1) ZA905618B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1300145A4 (en) * 2000-07-04 2004-07-07 Toray Industries PREVENTIVE OR THERAPEUTIC DRUGS FOR MOOD DISORDERS OR ANXIETY DISORDERS
DE502005005922D1 (de) * 2005-06-21 2008-12-18 Geke Technologie Gmbh Geschoss oder gefechtskopf
FR2936710B1 (fr) * 2008-10-07 2011-01-07 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
WO2011116282A2 (en) * 2010-03-19 2011-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nicotinic acetylcholine receptor agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA995670A (en) * 1970-10-05 1976-08-24 Wilson S. Waring Phenanthrolines and pyrido-quinolines
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
US4235909A (en) * 1979-04-19 1980-11-25 Eli Lilly And Company Octahydro-2H-pyrrolo[3,4-g]quinolines
PH22782A (en) * 1983-02-01 1988-12-12 Sandoz Ltd Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives
US4501890A (en) * 1983-09-26 1985-02-26 Eli Lilly And Company Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines
US4537893A (en) * 1984-04-27 1985-08-27 Eli Lilly And Company Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors
HU193338B (en) * 1984-08-02 1987-09-28 Lilly Co Eli Process for producing oktahydro-oxazolo/4,5-g/quinoline derivatives
US4659832A (en) * 1985-06-10 1987-04-21 Eli Lilly And Company Process for the preparation of octahydro-oxazolo [4,5-G]quinolines
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
I. Med. Chem. 23 (5). 481-491, 1980. *

Also Published As

Publication number Publication date
HUT54686A (en) 1991-03-28
HU207079B (en) 1993-03-01
HU904584D0 (en) 1990-12-28
JPH0395182A (ja) 1991-04-19
KR910002853A (ko) 1991-02-26
EP0410641A2 (en) 1991-01-30
ZA905618B (en) 1992-03-25
EP0410641A3 (en) 1991-04-17
MX21657A (es) 1993-12-01
IE902674A1 (en) 1991-02-27
CA2021314A1 (en) 1991-01-25
NZ234550A (en) 1992-03-26
AU5918490A (en) 1991-01-24
AU631228B2 (en) 1992-11-19
CN1049162A (zh) 1991-02-13
US4939259A (en) 1990-07-03
PT94749A (pt) 1991-03-20

Similar Documents

Publication Publication Date Title
RU1838308C (ru) Способ получени производных замещенного (1Н-азол-1-илметил)-бензтриазола или их фармацевтически приемлемых солей присоединени кислот
FI92582B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi
YU4680A (en) Process for obtaining new piperidinyl-alkyl-quinazoline derivatives
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
NO922185L (no) 1-metylkarbapenemderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som antibiotika
NO882588L (no) Fremgangsmaate ved fremstilling av substituerte inololinonderivater.
AT380471B (de) Verfahren zur herstellung von neuen 2-oxoazetidin-derivate
RU1836371C (ru) Способ получени производных 5,5а,6,7,8,9,9а,10-октагидропиридо (2,3- @ )-хинолина или их фармацевтически приемлемых солей
AU5608090A (en) Amines
IE820239L (en) Carbapenem derivatives
FR2479219B1 (ru)
IE43222L (en) Piperazine derivatives
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
ES8104302A1 (es) Un procedimiento para preparar un derivado de cefema
GB1469197A (en) Preparation of 1-aminoalkyl triazolobenzodiazepines
GB1417355A (en) Substituted piperazine and homopiperazine derivatives
ES8505178A1 (es) Procedimiento para la obtencion de derivados quinolinicos
CA2274530A1 (en) Process for producing 5-arylthio imidazole derivatives
ES8609250A1 (es) Un procedimiento para la preparacion de nuevos derivados de ftalimida.
IE40507L (en) Salicylamide derivatives
EP0192992A3 (en) Quinoxaline derivatives useful for treatment and prophilaxis of swine dysentery and as animal growth promotants
ES383905A1 (es) Un procedimiento para la preparacion de derivados de piri- midopiridazina.
ES8702394A1 (es) Procedimiento para preparar nuevos derivados de acido sulfa-moilbenzoico
ES8302703A1 (es) "un procedimiento para la preparacion de fenil-quinolicidinas".
JPS55160769A (en) Hydrazinophthalazine derivative